Table III.
Comparison of adverse reactions between the two groups [n (%)].
| Groups | ||||
|---|---|---|---|---|
| items | Combined therapy (n=50) | Oxaliplatin (n=51) | χ2 | P-value |
| Fever | 3 (6.00) | 2 (3.91) | 0.232 | 0.630 |
| Pain | 17 (34.00) | 15 (29.42) | 0.246 | 0.620 |
| Nausea and vomiting | 5 (10.00) | 3 (5.82) | 0.586 | 0.444 |
| Anorexia | 3 (6.00) | 2 (3.91) | 0.232 | 0.630 |
| Increased bilirubin | 12 (24.00) | 7 (13.73) | 1.745 | 0.187 |
| Hypoproteinemia | 6 (12.00) | 11 (21.57) | 1.651 | 0.199 |
| Thrombocytopenia | 5 (10.00) | 4 (7.84) | 0.145 | 0.704 |
| Anemia | 5 (10.00) | 6 (11.76) | 0.081 | 0.776 |
| Neurotoxicity | 11 (22.00) | 8 (15.69) | 0.659 | 0.417 |
| Renal toxicity | 1 (2.00) | 0 (0.00) | 0.490 | |